Your browser doesn't support javascript.
loading
Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry.
Ueshima, Daisuke; Ashikaga, Takashi; Yoshikawa, Shunji; Sasaoka, Taro; Hatano, Yu; Kurihara, Ken; Maejima, Yasuhiro; Isobe, Mitsuaki.
Afiliação
  • Ueshima D; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: daiucvm@tmd.ac.jp.
  • Ashikaga T; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yoshikawa S; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Sasaoka T; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Hatano Y; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kurihara K; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Maejima Y; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Isobe M; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
J Cardiol ; 69(6): 815-822, 2017 Jun.
Article em En | MEDLINE | ID: mdl-27692568

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Stents Farmacológicos / Intervenção Coronária Percutânea / Everolimo Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Stents Farmacológicos / Intervenção Coronária Percutânea / Everolimo Idioma: En Ano de publicação: 2017 Tipo de documento: Article